FeesSafety
Pluang+
Home/Explore/US Market Price/Stocks/ABCL
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

AbCellera Biologics Inc (ABCL) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

AbCellera Biologics (ABCL) trades at $12.28, up 0.82% with neutral technical signals despite recent positive momentum. The company shows improving revenue trends ($75M in 2025) but remains unprofitable with negative margins. Strong analyst support (91.7% buy ratings) and a $18.20 consensus target reflect optimism around ABCL635 Phase 2 success and recent $200M oversubscribed offering.
Investment outlook balances clinical progress against financial challenges. ABCL635's 83% reduction in menopausal hot flashes positions it as a potential blockbuster, but negative cash flow and high burn rate require careful monitoring. The stock offers substantial upside to analyst targets but carries biotech development risks and dependency on pipeline success.
Read full analysis

Key Stats

  • Market Cap
    $3.98B
  • Volume
    2,666,237
  • Sector
    Health
  • 52W High
    $14.82
  • 52W Low
    $2.78
  • Typical Hold Time
    42 Days
  • Enterprise Value
    $3.57B
  • Div Yield
    -
  • Trading Activity
    6% Sell | 94% Buy
$11
52W Low: $2.78
05 Feb 2026
52W High: $14.82
29 Sep 2026

Track AbCellera Biologics Inc (ABCL) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, AbCellera Biologics Inc has traded between a low of $2.78 and a high of $14.82, highlighting its annual price range. Buy and sell AbCellera Biologics Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About AbCellera Biologics Inc

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.

Most Recent News

Content is generated by Aura AI

Ariel Investments highlights gains in Consumer sectors but sees losses in IT and Industrials in Q3 2026.

Ariel Investments reported that in Q3 2026, their positive stock picks in Consumer Discretionary, Consumer Staples, and Health Care sectors contributed most to returns. However, their holdings in Information Technology and Industrials, along with an ...

Market News
5 hours ago
Seeking Alpha
Neutral
Ariel Investments highlights gains in Consumer sectors but sees losses in IT and Industrials in Q3 2026.

Blue Owl Capital's NAV rises to $14.32, ending a decline amid buybacks and earnings gains.

Blue Owl Capital Corporation's net asset value (NAV) increased to $14.32 per share as of September 30, reversing a multi-quarter decline. This improvement reflects better portfolio valuations, share repurchases at significant discounts, and earnings ...

Market News
6 hours ago
Seeking Alpha
Bullish
news icon
Blue Owl Capital's NAV rises to $14.32, ending a decline amid buybacks and earnings gains.

Alger Concentrated Equity ETF lags Russell 1000 Growth as tech leads Q3 2026 gains

In Q3 2026, U.S. equities rose modestly with the S&P 500 up 2%. The Alger Concentrated Equity ETF underperformed the Russell 1000 Growth Index despite gains in Information Technology and Communication Services sectors. Top contributors included Micro...

Market News
6 hours ago
Seeking Alpha
Neutral
Alger Concentrated Equity ETF lags Russell 1000 Growth as tech leads Q3 2026 gains
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $3.98B
  • Volume
    2,666,237
  • Sector
    Health
  • 52W High
    $14.82
  • 52W Low
    $2.78
  • Typical Hold Time
    42 Days
  • Enterprise Value
    $3.57B
  • Div Yield
    -
  • Trading Activity
    6% Sell | 94% Buy
$11
52W Low: $2.78
05 Feb 2026
52W High: $14.82
29 Sep 2026

Track AbCellera Biologics Inc (ABCL) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, AbCellera Biologics Inc has traded between a low of $2.78 and a high of $14.82, highlighting its annual price range. Buy and sell AbCellera Biologics Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!